Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 07, 2014 08:30 ET | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Approved for Approximately $1.5 Million From New Jersey's Technology Business Tax Certificate Transfer Program

EWING, N.J., Jan. 7, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, announced today that...
December 19, 2013 08:30 ET | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Appoints Joseph M. Lobacki to Board of Directors

EWING, N.J., Dec. 19, 2013 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the...
December 12, 2013 08:30 ET | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Announces Positive Data and Safety Monitoring Board Recommendation for CPX-351 Phase 3 Study

EWING, N.J., Dec. 12, 2013 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...
December 06, 2013 08:30 ET | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals to Present at Oppenheimer 24th Annual Healthcare Conference

EWING, N.J., Dec. 6, 2013 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...
December 03, 2013 08:30 ET | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Announces Appointment of Derek Miller as Chief Business Officer

EWING, N.J., Dec. 3, 2013 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the...
November 12, 2013 16:00 ET | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Announces Business Update and Third Quarter 2013 Financial Results

EWING, N.J., Nov. 12, 2013 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today reported third...
November 12, 2013 07:30 ET | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Announces Appointment of Les Mintzmyer as Vice-President Manufacturing and Technical Operations

EWING, N.J., Nov. 12, 2013 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the...
November 07, 2013 13:47 ET | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Announces Listing on NASDAQ Under Symbol "CPXX"

EWING, N.J., Nov. 7, 2013 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (OTCBB:CLPM), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that its...
November 06, 2013 16:36 ET | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals to Webcast Conference Call Discussing Third Quarter 2013 Financial Results on November 12, 2013

EWING, N.J., Nov. 6, 2013 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc., (OTCBB:CLPM), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that it...